1
|
Di Gennaro F, Cotugno S, Guido G, Cavallin F, Papagni R, De Vita E, Manco Cesari G, Di Gregorio S, Giliberti V, Cassano D, Metrangolo G, Amendolara A, Francabandiera A, Fiorella M, Lobalsamo V, Brindicci G, Santoro CR, Ronga L, Lattanzio R, De Iaco G, Saracino A. Impact of a TB Team on TB Outcomes: A 2016-2024 Pre-Post Study From a Referral Center in Southern Italy. Open Forum Infect Dis 2025; 12:ofaf258. [PMID: 40376187 PMCID: PMC12079650 DOI: 10.1093/ofid/ofaf258] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/05/2025] [Accepted: 04/24/2025] [Indexed: 05/18/2025] Open
Abstract
Background Tuberculosis (TB) remains a major global public health challenge, requiring innovative management strategies to improve patient outcomes and reduce disease burden. Despite advancements in diagnostics and treatment, TB continues to cause significant morbidity and mortality worldwide, particularly among vulnerable populations such as migrants and individuals with limited healthcare access. The World Health Organization has emphasized the need for patient-centered approaches, including the establishment of TB-dedicated teams, to enhance care coordination and improve outcomes. However, real-world evidence on their effectiveness remains limited. Methods We conducted a retrospective before-after study to evaluate the impact of a structured TB-dedicated team implemented at a referral hospital in Southern Italy between 2016 and 2024. Prior to 2020, TB care was unstructured, with patients being followed by different physicians without a standardized system. Between 2021 and 2024, a dedicated TB team was established, comprising 2 infectious disease specialists, infectious disease residents, and a senior professor overseeing scientific activities. This new model introduced key interventions, including a dedicated outpatient reservation system, directly observed therapy, structured follow-up, specialist networking, systematic data collection, and targeted counseling on risk behaviors and comorbidities. Primary outcomes included treatment success rates, hospital length of stay, incidence of adverse events, and patient retention in follow-up programs. All tests were 2-sided and a P-value <.05 was considered statistically significant. Statistical analysis was carried out using R 4.4. Results A total of 269 TB patients were analyzed (117 pre- and 152 postimplementation). The introduction of the TB team was associated with a significant reduction in loss to follow-up (41.9% to 3.7%; P < .0001; odds ratio, 0.04; 95% confidence interval, .01-.12) and incomplete treatments (41.9% to 12.0; P < .0001; odds ratio, 0.13; 95% confidence interval, .06-.29). Median hospital stay decreased from 28 to 14 days (P < .0001), whereas adverse events remained comparable (32.5% vs 29.6%, P = .71). Conclusions The implementation of a TB-dedicated team significantly improved TB management by enhancing treatment adherence, reducing hospitalization, and preventing loss to follow-up. Given the public health impact of TB, structured care models should be prioritized to optimize patient outcomes and strengthen health system efficiency.
Collapse
Affiliation(s)
- Francesco Di Gennaro
- Department of Precision and Regenerative Medicine and Jonian Area (DiMePreJ), Clinic of Infectious Diseases, University of Bari Aldo Moro, Bari, Italy
| | - Sergio Cotugno
- Department of Precision and Regenerative Medicine and Jonian Area (DiMePreJ), Clinic of Infectious Diseases, University of Bari Aldo Moro, Bari, Italy
| | - Giacomo Guido
- Department of Precision and Regenerative Medicine and Jonian Area (DiMePreJ), Clinic of Infectious Diseases, University of Bari Aldo Moro, Bari, Italy
| | | | - Roberta Papagni
- Department of Precision and Regenerative Medicine and Jonian Area (DiMePreJ), Clinic of Infectious Diseases, University of Bari Aldo Moro, Bari, Italy
| | - Elda De Vita
- Department of Precision and Regenerative Medicine and Jonian Area (DiMePreJ), Clinic of Infectious Diseases, University of Bari Aldo Moro, Bari, Italy
| | - Giorgia Manco Cesari
- Department of Precision and Regenerative Medicine and Jonian Area (DiMePreJ), Clinic of Infectious Diseases, University of Bari Aldo Moro, Bari, Italy
| | - Stefano Di Gregorio
- Department of Precision and Regenerative Medicine and Jonian Area (DiMePreJ), Clinic of Infectious Diseases, University of Bari Aldo Moro, Bari, Italy
| | - Vincenzo Giliberti
- Department of Precision and Regenerative Medicine and Jonian Area (DiMePreJ), Clinic of Infectious Diseases, University of Bari Aldo Moro, Bari, Italy
| | - Domenica Cassano
- Department of Precision and Regenerative Medicine and Jonian Area (DiMePreJ), Clinic of Infectious Diseases, University of Bari Aldo Moro, Bari, Italy
| | - Giuliana Metrangolo
- Department of Precision and Regenerative Medicine and Jonian Area (DiMePreJ), Clinic of Infectious Diseases, University of Bari Aldo Moro, Bari, Italy
| | - Angela Amendolara
- Department of Precision and Regenerative Medicine and Jonian Area (DiMePreJ), Clinic of Infectious Diseases, University of Bari Aldo Moro, Bari, Italy
| | - Alessandro Francabandiera
- Department of Precision and Regenerative Medicine and Jonian Area (DiMePreJ), Clinic of Infectious Diseases, University of Bari Aldo Moro, Bari, Italy
| | - Monica Fiorella
- Department of Precision and Regenerative Medicine and Jonian Area (DiMePreJ), Clinic of Infectious Diseases, University of Bari Aldo Moro, Bari, Italy
| | - Vittoria Lobalsamo
- Department of Precision and Regenerative Medicine and Jonian Area (DiMePreJ), Clinic of Infectious Diseases, University of Bari Aldo Moro, Bari, Italy
| | - Gaetano Brindicci
- Department of Precision and Regenerative Medicine and Jonian Area (DiMePreJ), Clinic of Infectious Diseases, University of Bari Aldo Moro, Bari, Italy
| | - Carmen Rita Santoro
- Department of Precision and Regenerative Medicine and Jonian Area (DiMePreJ), Clinic of Infectious Diseases, University of Bari Aldo Moro, Bari, Italy
| | - Luigi Ronga
- Microbiology and Virology Unit, University of Bari, University Hospital Policlinico, Bari, Italy
| | - Rossana Lattanzio
- Department of Precision and Regenerative Medicine and Jonian Area (DiMePreJ), Clinic of Infectious Diseases, University of Bari Aldo Moro, Bari, Italy
| | - Giuseppina De Iaco
- Department of Precision and Regenerative Medicine and Jonian Area (DiMePreJ), Clinic of Infectious Diseases, University of Bari Aldo Moro, Bari, Italy
| | - Annalisa Saracino
- Department of Precision and Regenerative Medicine and Jonian Area (DiMePreJ), Clinic of Infectious Diseases, University of Bari Aldo Moro, Bari, Italy
| |
Collapse
|
2
|
Godoy S, Alsedà M, Parrón I, Millet JP, Caylà JA, Follia N, Carol M, Orcau A, Toledo D, Ferrús G, Plans P, Barrabeig I, Clotet L, Domínguez A, March-Llanes J, Godoy P. Exposure Time to a Tuberculosis Index Case as a Marker of Infection in Immigrant Populations. Pathogens 2025; 14:175. [PMID: 40005550 PMCID: PMC11858108 DOI: 10.3390/pathogens14020175] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/03/2024] [Revised: 01/27/2025] [Accepted: 02/07/2025] [Indexed: 02/27/2025] Open
Abstract
Background: Exposure time to a tuberculosis (TB) index case may be a marker of a recent latent tuberculosis infection (LTBI) risk. The aim of this study was to determine the LTBI risk involved in immigrant contact based on exposure time to pulmonary TB index cases. Methods: We conducted a 30-month LTBI prevalence study of pulmonary TB immigrant contacts in Catalonia (1 January 2019-30 June 2021). Contacts with LTBI were identified by means of the tuberculin skin test and/or interferon gamma release assay. Variables associated with LTBI in contacts were analysed using adjusted OR (aOR) and 95% confidence interval (CI) values. Results: LTBI prevalence was 37.4% (939/2509). Prevalence was higher in men than women (40.6% versus 33.5%; p < 0.001), and in all age groups, relative to children <5 years (12.2%; p < 0.001)). Prevalence increased with exposure time to the index case; relative to <6 h/week exposure, LTBI risk was greater for both ≥6 h/day (aOR = 2.0; 95% CI: 1.5-2.6) and <6 h/day but ≥6 h/week (aOR = 1.6; 95% CI: 1.1-2.2). Conclusions: The LTBI risk in immigrant contacts increases with recent exposure time to the index case, and may suggest recent LTBI in immigrants.
Collapse
Affiliation(s)
- Sofia Godoy
- Institut de Recerca Biomédica de Lleida (IRBLleida), Universitat de Lleida, 25198 Lleida, Spain; (S.G.); (M.A.)
- Institut Català de la Salut, 25600 Lleida, Spain
| | - Miquel Alsedà
- Institut de Recerca Biomédica de Lleida (IRBLleida), Universitat de Lleida, 25198 Lleida, Spain; (S.G.); (M.A.)
- Agència de Salut Pública Catalunya, 08005 Barcelona, Spain; (I.P.); (N.F.); (M.C.); (G.F.); (P.P.); (I.B.); (L.C.)
| | - Ignasi Parrón
- Agència de Salut Pública Catalunya, 08005 Barcelona, Spain; (I.P.); (N.F.); (M.C.); (G.F.); (P.P.); (I.B.); (L.C.)
| | - Joan-Pau Millet
- Consorcio de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), 20029 Madrid, Spain; (J.-P.M.); (D.T.); (A.D.)
- Barcelona Tuberculosis Research Unit Foundation, 08008 Barcelona, Spain;
- Agència de Salut Pública de Barcelona, 08023 Barcelona, Spain;
| | - Joan A. Caylà
- Barcelona Tuberculosis Research Unit Foundation, 08008 Barcelona, Spain;
| | - Núria Follia
- Agència de Salut Pública Catalunya, 08005 Barcelona, Spain; (I.P.); (N.F.); (M.C.); (G.F.); (P.P.); (I.B.); (L.C.)
| | - Monica Carol
- Agència de Salut Pública Catalunya, 08005 Barcelona, Spain; (I.P.); (N.F.); (M.C.); (G.F.); (P.P.); (I.B.); (L.C.)
| | - Angels Orcau
- Agència de Salut Pública de Barcelona, 08023 Barcelona, Spain;
| | - Diana Toledo
- Consorcio de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), 20029 Madrid, Spain; (J.-P.M.); (D.T.); (A.D.)
- Departament de Medicina, Universitat de Barcelona, 08036 Barcelona, Spain
| | - Gloria Ferrús
- Agència de Salut Pública Catalunya, 08005 Barcelona, Spain; (I.P.); (N.F.); (M.C.); (G.F.); (P.P.); (I.B.); (L.C.)
| | - Pere Plans
- Agència de Salut Pública Catalunya, 08005 Barcelona, Spain; (I.P.); (N.F.); (M.C.); (G.F.); (P.P.); (I.B.); (L.C.)
- Consorcio de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), 20029 Madrid, Spain; (J.-P.M.); (D.T.); (A.D.)
| | - Irene Barrabeig
- Agència de Salut Pública Catalunya, 08005 Barcelona, Spain; (I.P.); (N.F.); (M.C.); (G.F.); (P.P.); (I.B.); (L.C.)
| | - Laura Clotet
- Agència de Salut Pública Catalunya, 08005 Barcelona, Spain; (I.P.); (N.F.); (M.C.); (G.F.); (P.P.); (I.B.); (L.C.)
| | - Angela Domínguez
- Consorcio de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), 20029 Madrid, Spain; (J.-P.M.); (D.T.); (A.D.)
- Departament de Medicina, Universitat de Barcelona, 08036 Barcelona, Spain
| | - Jaume March-Llanes
- Departament de Psicologia, Sociologia i Treball Social, Universitat de Lleida, 25001 Lleida, Spain;
| | - Pere Godoy
- Institut de Recerca Biomédica de Lleida (IRBLleida), Universitat de Lleida, 25198 Lleida, Spain; (S.G.); (M.A.)
- Consorcio de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), 20029 Madrid, Spain; (J.-P.M.); (D.T.); (A.D.)
- Hospital Universitari de Santa Maria, 25198 Lleida, Spain
| | | |
Collapse
|
3
|
Yu S, Jeong D, Kang HY, Kang YA, Lee GI, Choi H. A Quasi-experimental Study on the Effect of Pre-entry Tuberculosis Screening for Immigrants on Treatment Outcomes in South Korea: A Difference-in-Differences Analysis. J Epidemiol Glob Health 2024; 14:154-161. [PMID: 38261173 PMCID: PMC11043236 DOI: 10.1007/s44197-023-00181-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/30/2022] [Accepted: 12/11/2023] [Indexed: 01/24/2024] Open
Abstract
OBJECTIVE This study ascertains the effects of the pre-entry tuberculosis (TB) screening policy, which was implemented as a strategy for managing TB among immigrants, on the treatment outcomes of immigrants in South Korea. METHODS This study linked three different datasets from 2013 to 2018, namely (1) Korean National Tuberculosis Surveillance System; (2) National Health Information Database for patients diagnosed with TB with ICD code A15-A19, B90, or U84.3; and (3) Statistics Korea database related to cause of deaths. To identify the effect of the policy, cohorts comprising Korean and immigrant TB patients notified before (January 1, 2013-December 31, 2015) and after (September 1, 2016-December 31, 2018), the implementations of the policy were established. A difference-in-differences (DID) analysis of the treatment success and mortality rates was performed. RESULTS Data from 100,262 TB patients were included in the analysis (before policy implementation: 1240 immigrants and 65,723 Koreans; after policy implementation: 256 immigrants and 33,043 Koreans). The propensity score matching-DID analysis results showed that the difference in the treatment success rate between immigrants and Koreans decreased significantly, from 16% before to 6% after the policy implementation. The difference in the mortality rate between the two groups decreased from - 3% before to - 1% after the policy implementation; however, this difference was insignificant. CONCLUSION The treatment outcomes of immigrant TB patients in South Korea improved after the implementation of the pre-entry active TB screening policy. Future immigrant TB policies should consider establishing active patient support strategies and a healthcare collaboration system between countries.
Collapse
Affiliation(s)
- Sarah Yu
- School of Health Policy and Management, College of Health Science, Korea University, Seoul, Republic of Korea
- BK21 FOUR R&E Center for Learning Health Systems, Korea University, Seoul, Republic of Korea
| | - Dawoon Jeong
- Department of Preventive Medicine, Seoul National University, Seoul, Republic of Korea
| | - Hee-Yeon Kang
- Department of Cancer Control and Population Health, National Cancer Center Graduate School of Cancer Science and Policy, Goyang, Republic of Korea
| | - Young Ae Kang
- Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea
- Institute for Immunology and Immunological Disease, Yonsei University College of Medicine, Seoul, Republic of Korea
| | - Gyeong In Lee
- The Korean Institute of Tuberculosis, Korean National Tuberculosis Association, Cheongju, Republic of Korea
| | - Hongjo Choi
- School of Health Policy and Management, College of Health Science, Korea University, Seoul, Republic of Korea.
- BK21 FOUR R&E Center for Learning Health Systems, Korea University, Seoul, Republic of Korea.
- Department of Preventive Medicine, College of Medicine, Konyang University, Daejeon, Republic of Korea.
| |
Collapse
|
4
|
Biddle L, Wahedi K, Bozorgmehr K. Comparable worth of life for all? Conducting and disseminating health economic evaluations for refugees in Germany. Global Health 2022; 18:48. [PMID: 35550577 PMCID: PMC9096763 DOI: 10.1186/s12992-022-00845-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/05/2021] [Accepted: 05/04/2022] [Indexed: 11/25/2022] Open
Abstract
Comparative health economic evaluation is based on premise of being able to compare the worth of a year of life lived in full quality across different patients, population groups, settings and interventions. Given the rising numbers of forcibly displaced people, the nexus of economics, migration and health has emerged as a central theme in recent conceptual and empirical approaches. However, some of the assumptions made in conventional economic approaches do not hold true in the decision-making context of migration and the health of forcibly displaced populations. Using the experience of conducting and disseminating economic analyses to support decision-making on health screening policies for refugees in Germany, we show that in particular the assumptions of individual utility with no positive externalities, equity-blind utilitarian ethical stances and stable budgets are challenged. The further development of methods to address these challenges are required to support decision-makers in this contentious and politically fraught context and continue to make choices and decisions transparent.
Collapse
Affiliation(s)
- Louise Biddle
- Section for Health Equity Studies and Migration, Department of General Practice and Health Services Research, University Hospital Heidelberg, Heidelberg, Germany.,Department of Population Medicine and Health Services Research, School of Public Health, Bielefeld University, Bielefeld, Germany
| | - Katharina Wahedi
- Section for Health Equity Studies and Migration, Department of General Practice and Health Services Research, University Hospital Heidelberg, Heidelberg, Germany
| | - Kayvan Bozorgmehr
- Section for Health Equity Studies and Migration, Department of General Practice and Health Services Research, University Hospital Heidelberg, Heidelberg, Germany. .,Department of Population Medicine and Health Services Research, School of Public Health, Bielefeld University, Bielefeld, Germany.
| |
Collapse
|
5
|
Importance of Tuberculosis Screening of Resident Visa Applicants in Low TB Incidence Settings: Experience from Oman. J Epidemiol Glob Health 2022; 12:281-291. [PMID: 35469117 PMCID: PMC9037058 DOI: 10.1007/s44197-022-00040-w] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/06/2022] [Accepted: 04/05/2022] [Indexed: 11/17/2022] Open
Abstract
Introduction For Oman, a country targeting tuberculosis (TB) elimination, TB among expatriates is a major challenge. Thus, screening for active TB using chest X-ray was made mandatory for expatriates’ residency renewals. Objective To estimate the incidence of bacteriologically confirmed TB and assess impact of chest X-ray based TB screening among expatriates in Muscat Governorate. Methods Applicants for residency and renewals were mandated for chest X-ray-based TB screening in 2018. We collected data of screened subjects with radiological suspicion of TB who were subjected to further bacteriological evaluation. Results Of 501,290 applicants screened during the study period, 436 (0.09%) had X-ray findings suggestive of TB. Among the 436, TB was confirmed in 53 (12.2%; 95% CI 9.2–15.6), giving an overall prevalence of 10.6 (95% CI 8–13.9) per 100,000 applicants (number needed to be screened 9458). Among renewals, the point prevalence of TB was 10.5 per 100,000 expatriates screened (95% CI 6.9–14.04 per 100,000), with a mean follow-up period of 11.8 years. Conclusion Our findings are consistent with the recommendation for utilization of chest X-ray as a preferred tool for active case finding in the setting of expatriate screening. Our findings are also suggestive of the need for latent TB screening and ruling out TB prior to latent TB treatment.
Collapse
|
6
|
Al-Hatimy F, Farooq A, Al Abiad M, Yerramsetti S, Al-Nesf MA, Manickam C, Al-Thani MH, Al-Khater AH, Samsam W, Mohamed-Ali V, Al-Maadheed M. A Retrospective Study of Non-Communicable Diseases amongst Blue-Collar Migrant Workers in Qatar. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH 2022; 19:ijerph19042266. [PMID: 35206454 PMCID: PMC8872334 DOI: 10.3390/ijerph19042266] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 12/01/2021] [Revised: 02/01/2022] [Accepted: 02/11/2022] [Indexed: 11/22/2022]
Abstract
Background: South Asian workers have a greater predisposition to non-communicable diseases (NCDs) that is exacerbated by migration and length of residence in host countries. Aims: To examine the association between length of residence in Qatar with diagnosis of NCDs in male blue-collar workers. Methods: A retrospective investigation of the electronic health records (EHRs) of 119,581 clinical visits by 58,342 patients was conducted. Data included age, nationality and confirmed ICD-10 diagnosis. Based on duration of residence, the population was divided into groups: ≤6 months, 6–12 months, 1–≤2 years, 2–≤5 years, 5–≤6 years, >6 years. It was assumed that the group that had been resident in Qatar for ≤6 months represented diseases that had been acquired in their countries of origin. Results: South Asian (90%) patients presented with NCDs at a younger (mean ± SD age of 34.8 ± 9.0 years) age. Diabetes and hypertension were higher in those who had just arrived (<6 months’ group), compared to the other durations of residence groups. Conversely, acute respiratory infections, as well as dermatitis and eczema, all increased, perhaps a consequence of shared living/working facilities. Only patients with diabetes and hypertension visited the clinic multiple times, and the cost of medication for these NCDs was affordable, relative to earnings. Discussion/Conclusions: Blue-collar workers were predominantly South Asian, from lower socioeconomic classes, with early onset chronic NCDs. Notably, residence in Qatar gave them better access to affordable, significantly subsidized healthcare, leading to effective management of these chronic conditions.
Collapse
Affiliation(s)
- Fatima Al-Hatimy
- Anti-Doping Laboratory Qatar, Sports City Road, Doha P. O. Box 27775, Qatar; (F.A.-H.); (A.F.); (C.M.); (W.S.); (V.M.-A.)
- Center of Metabolism and Inflammation, Division of Medicine, Royal Free Campus, University College London, Rowland Hill Road, London NW3 2PF, UK;
| | - Abdulaziz Farooq
- Anti-Doping Laboratory Qatar, Sports City Road, Doha P. O. Box 27775, Qatar; (F.A.-H.); (A.F.); (C.M.); (W.S.); (V.M.-A.)
- Aspetar, Orthopaedic and Sports Medicine Hospital, FIFA Medical Centre of Excellence, Doha P. O. Box 29222, Qatar
| | - Mohamad Al Abiad
- Qatar Red Crescent Society, Doha P. O. Box 5449, Qatar; (M.A.A.); (S.Y.); (A.-H.A.-K.)
| | - Shilpi Yerramsetti
- Qatar Red Crescent Society, Doha P. O. Box 5449, Qatar; (M.A.A.); (S.Y.); (A.-H.A.-K.)
| | - Maryam Ali Al-Nesf
- Center of Metabolism and Inflammation, Division of Medicine, Royal Free Campus, University College London, Rowland Hill Road, London NW3 2PF, UK;
- Hamad Medical Corporation, Doha P. O. Box 3050, Qatar
| | - Chidambaram Manickam
- Anti-Doping Laboratory Qatar, Sports City Road, Doha P. O. Box 27775, Qatar; (F.A.-H.); (A.F.); (C.M.); (W.S.); (V.M.-A.)
| | | | - Al-Hareth Al-Khater
- Qatar Red Crescent Society, Doha P. O. Box 5449, Qatar; (M.A.A.); (S.Y.); (A.-H.A.-K.)
- Hamad Medical Corporation, Doha P. O. Box 3050, Qatar
| | - Waseem Samsam
- Anti-Doping Laboratory Qatar, Sports City Road, Doha P. O. Box 27775, Qatar; (F.A.-H.); (A.F.); (C.M.); (W.S.); (V.M.-A.)
| | - Vidya Mohamed-Ali
- Anti-Doping Laboratory Qatar, Sports City Road, Doha P. O. Box 27775, Qatar; (F.A.-H.); (A.F.); (C.M.); (W.S.); (V.M.-A.)
- Center of Metabolism and Inflammation, Division of Medicine, Royal Free Campus, University College London, Rowland Hill Road, London NW3 2PF, UK;
| | - Mohammed Al-Maadheed
- Anti-Doping Laboratory Qatar, Sports City Road, Doha P. O. Box 27775, Qatar; (F.A.-H.); (A.F.); (C.M.); (W.S.); (V.M.-A.)
- Center of Metabolism and Inflammation, Division of Medicine, Royal Free Campus, University College London, Rowland Hill Road, London NW3 2PF, UK;
- Correspondence:
| |
Collapse
|
7
|
Degeling C, Carter SM, Dale K, Singh K, Watts K, Hall J, Denholm J. Perspectives of Vietnamese, Sudanese and South Sudanese immigrants on targeting migrant communities for latent tuberculosis screening and treatment in low-incidence settings: A report on two Victorian community panels. Health Expect 2020; 23:1431-1440. [PMID: 32918523 PMCID: PMC7752196 DOI: 10.1111/hex.13121] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/07/2020] [Revised: 07/15/2020] [Accepted: 07/21/2020] [Indexed: 12/21/2022] Open
Abstract
BACKGROUND Tuberculosis (TB) elimination strategies in Australia require a focus on groups who are at highest risk of TB infection, such as immigrants from high-burden settings. Understanding attitudes to different strategies for latent TB infection (LTBI) screening and treatment is an important element of justifiable elimination strategies. METHOD Two community panels were conducted in Melbourne with members of the Vietnamese (n = 11), Sudanese and South Sudanese communities (n = 9). Panellists were provided with expert information about LTBI and different screening and health communication strategies, then deliberated on how best to pursue TB elimination in Australia. FINDINGS Both panels unanimously preferred LTBI screening to occur pre-migration rather than in Australia. Participants were concerned that post-migration screening would reach fewer migrants, noted that conducting LTBI screening in Australia could stigmatize participants and that poor awareness of LTBI would hamper participation. If targeted screening was to occur in Australia, the Vietnamese panel preferred 'place-based' communication strategies, whereas the Sudanese and South Sudanese panel emphasized that community leaders should lead communication strategies to minimize stigma. Both groups emphasized the importance of maintaining community trust in Australian health service providers, and the need to ensure targeting did not undermine this trust. CONCLUSION Pre-migration screening was preferred. If post-migration screening is necessary, the potential for stigma should be reduced, benefit and risk profile clearly explained and culturally appropriate communication strategies employed. Cultural attitudes to health providers, personal health management and broader social vulnerabilities of targeted groups need to be considered in the design of screening programs.
Collapse
Affiliation(s)
- Chris Degeling
- Australian Centre for Health Engagement Evidence and ValuesSchool of Health & SocietyUniversity of WollongongWollongongNSWAustralia
| | - Stacy M. Carter
- Australian Centre for Health Engagement Evidence and ValuesSchool of Health & SocietyUniversity of WollongongWollongongNSWAustralia
| | - Katie Dale
- Victorian Tuberculosis ProgramMelbourne Health at The Doherty Institute for Infection & ImmunityMelbourneVICAustralia
- Department of Microbiology and ImmunologyUniversity of MelbourneMelbourneVICAustralia
| | - Kasha Singh
- Victorian Infectious Diseases ServiceMelbourne Health at The Doherty Institute for Infection & ImmunityMelbourneVICAustralia
| | - Krista Watts
- Victorian Tuberculosis ProgramMelbourne Health at The Doherty Institute for Infection & ImmunityMelbourneVICAustralia
| | - Julie Hall
- Australian Centre for Health Engagement Evidence and ValuesSchool of Health & SocietyUniversity of WollongongWollongongNSWAustralia
| | - Justin Denholm
- Victorian Tuberculosis ProgramMelbourne Health at The Doherty Institute for Infection & ImmunityMelbourneVICAustralia
- Department of Microbiology and ImmunologyUniversity of MelbourneMelbourneVICAustralia
| |
Collapse
|
8
|
Wahedi K, Biddle L, Bozorgmehr K. Cost-effectiveness of targeted screening for active pulmonary tuberculosis among asylum-seekers: A modelling study with screening data from a German federal state (2002-2015). PLoS One 2020; 15:e0241852. [PMID: 33151980 PMCID: PMC7644037 DOI: 10.1371/journal.pone.0241852] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/16/2020] [Accepted: 10/21/2020] [Indexed: 11/19/2022] Open
Abstract
Screening asylum-seekers for active pulmonary tuberculosis is common practice among many European countries with low incidence of tuberculosis. The reported yields vary substantially, partly due to the heterogeneous and dynamic nature of asylum-seeking populations. Rather than screening all new arrivals (indiscriminate screening), a few countries apply targeted screening based on incidence of tuberculosis in asylum-seekers' country of origin. However, evaluations of its cost-effectiveness have been scarce. The aim of this modelling study was to assess whether the introduction of a screening threshold based on the tuberculosis incidence in the country of origin is sensible from an economic perspective. To this end, we compare the current, indiscriminate screening policy for pulmonary tuberculosis in Germany with a hypothetical targeted screening programme using several potential screening thresholds based on WHO-reported incidence of tuberculosis in countries of origin. Screening data is taken from a large German federal state over 14 years (2002-2015). Incremental cost-effectiveness is measured as cost per case found and cost per case prevented. Our analysis shows that incremental cost-effectiveness ratios (ICERs) of screening asylum-seekers from countries with an incidence of 50 to 250/100,000 range between 15,000€ and 17,000€ per additional case found when compared to lower thresholds. The ICER for screening asylum-seekers from countries with an incidence <50/100,000 is 112,000€ per additional case found. Costs per case prevented show a similar increase in costs. The high cost per case found and per case prevented at the <50/100,000 threshold scenario suggests this threshold to be a sensible cut-off for targeted screening. Acknowledging that no screening measure can find all cases of tuberculosis, and that reactivation of latent infections makes up a large proportion of foreign-born cases, targeting asylum-seekers from countries with an incidence above 50/100,000 is likely to be a more reasonable screening measure for the prevention and control of tuberculosis than indiscriminate screening measures.
Collapse
Affiliation(s)
- Katharina Wahedi
- Department of General Practice and Health Services Research, University Hospital Heidelberg, Heidelberg, Germany
| | - Louise Biddle
- Department of General Practice and Health Services Research, University Hospital Heidelberg, Heidelberg, Germany
| | - Kayvan Bozorgmehr
- Department of General Practice and Health Services Research, University Hospital Heidelberg, Heidelberg, Germany
- Department of Population Medicine and Health Services Research, School of Public Health, Bielefeld University, Bielefeld, Germany
| |
Collapse
|
9
|
Scandurra G, Degeling C, Douglas P, Dobler CC, Marais B. Tuberculosis in migrants - screening, surveillance and ethics. Pneumonia (Nathan) 2020; 12:9. [PMID: 32923311 PMCID: PMC7473829 DOI: 10.1186/s41479-020-00072-5] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/28/2020] [Accepted: 07/29/2020] [Indexed: 12/13/2022] Open
Abstract
Tuberculosis (TB) is the leading infectious cause of human mortality and is responsible for nearly 2 million deaths every year. It is often regarded as a 'silent killer' because it predominantly affects the poor and marginalized, and disease outbreaks occur in 'slow motion' compared to Ebola or coronavirus 2 (COVID-19). In low incidence countries, TB is predominantly an imported disease and TB control in migrants is pivotal for countries to progress towards TB elimination in accordance with the World Health Organisations (WHO's) End TB strategy. This review provides a brief overview of the different screening approaches and surveillance processes that are in place in low TB incidence countries. It also includes a detailed discussion of the ethical issues related to TB screening of migrants in these settings and the different interests that need to be balanced. Given recognition that a holistic approach that recognizes and respects basic human rights is required to end TB, the review considers the complexities that require consideration in low-incidence countries that are aiming for TB elimination.
Collapse
Affiliation(s)
- Gabriella Scandurra
- Marie Bashir Institute for Infectious Diseases and Biosecurity, The University of Sydney, Sydney, Australia
| | - Chris Degeling
- Australian Centre for Health Engagement Evidence and Values, University of Wollongong, Wollongong, Australia
| | - Paul Douglas
- International Organization for Migration (IOM), Geneva, Switzerland
| | - Claudia C. Dobler
- Institute for Evidenced-Based Healthcare, Bond University, Gold Coast, Australia
| | - Ben Marais
- Marie Bashir Institute for Infectious Diseases and Biosecurity, The University of Sydney, Sydney, Australia
| |
Collapse
|
10
|
Gulliford M, Garner-Purkis A. Tuberculosis testing and migrant health. THE LANCET. INFECTIOUS DISEASES 2019; 19:1151-1152. [PMID: 31471130 DOI: 10.1016/s1473-3099(19)30314-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/31/2019] [Accepted: 06/04/2019] [Indexed: 06/10/2023]
Affiliation(s)
- Martin Gulliford
- School of Population Health and Environmental Sciences, King's College London, London, SE1 1UL, UK.
| | - Aphra Garner-Purkis
- School of Population Health and Environmental Sciences, King's College London, London, SE1 1UL, UK
| |
Collapse
|